Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - World-news https://ift.tt/3nX8fwP
Resent New
Discord abandons Microsoft acquisition talks: Report
Discussion platform Discord, popular among amateur video game players, has halted acquisition talks with Microsoft and is instead considerin...
